Pharmicell Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 18.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.25%	Hyun-Soo Kim	5,549,716	₩31.1b	0%	no data
4.06%	National Pension Service	2,437,429	₩13.6b	0%	0.01%
3.16%	The Vanguard Group, Inc.	1,896,431	₩10.6b	0.62%	no data
0.59%	Dimensional Fund Advisors LP	353,412	₩2.0b	-0.11%	no data
0.48%	Samsung Asset Management Company, Ltd.	290,094	₩1.6b	0%	0.01%
0.4%	Mirae Asset Global Investments Co., Ltd.	238,732	₩1.3b	-0.14%	no data
0.38%	Pharmicell Co., Ltd, Employee Stock Ownership Association	226,558	₩1.3b	-0.75%	no data
0.17%	Charles Schwab Investment Management, Inc.	104,248	₩583.8m	-0.69%	no data
0.12%	Midas Asset Management	72,928	₩408.4m	1.11%	0.03%
0.12%	State Street Global Advisors, Inc.	71,161	₩398.5m	0.3%	no data
0.083%	Byung-Moo Yoo	50,000	₩280.0m	0%	no data
0.025%	American Century Investment Management Inc	15,136	₩84.7m	0%	no data
0.016%	Hanwha Asset Management Co. Ltd.	9,840	₩55.1m	0%	no data
0.009%	NH-Amundi Asset Management	5,374	₩30.1m	0%	no data
0.0033%	Gil-Soo Jeong	2,000	₩11.2m	0%	no data
0.0015%	Midas Asset Management Co. Ltd.	915	₩5.1m	0%	0.07%
0.0006%	Invesco Capital Management LLC	359	₩2.0m	0%	no data
0.00056%	DB Asset Management Co., Ltd.	336	₩1.9m	-72.4%	no data
0.00034%	Korea Investment Management Co., Ltd.	205	₩1.1m	0%	no data